Purchase Order 36C26121P1077
- Not listed
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Denver Solutions, LLC, an FDA-registered 503B outsourcing provider. The $97,431.43 contract is for the delivery of sterile compound products, including injectables like ropivacaine, ketamine, phenylephrine, and ephedrine, as well as sterile compound kits and LEITERS (liquid-filled implantable drug delivery systems). The contract is not set-aside and runs through September 30, 2022. In...
- This is a $125,722.90 firm fixed-price purchase order awarded by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA) to Denver Solutions, LLC, a for-profit limited liability company. The contract is for the delivery of the pharmaceutical product ropivacaine hydrochloride injection to support VA medical facilities. Denver Solutions is an FDA-registered 503B outsourcing facility that specializes in compounded sterile pharmaceutical products,...
- The U.S. Department of Veterans Affairs (VA) awarded a $36,295.60 firm fixed-price delivery order contract to Denver Solutions, LLC, a for-profit limited liability company, to provide 503B compounded sterile pharmaceutical products to federal healthcare agencies. The contract has no set-aside designation and is valid through September 30, 2024. Denver Solutions specializes in providing specialized injectable medications, sterile compound kits, and liquid-filled implantable drug delivery...
- Denver Solutions, LLC, an FDA-registered 503B outsourcing facility specializing in compounded sterile pharmaceuticals, was awarded a delivery order valued at $53,375 by Veterans Integrated Service Network 23 (VISN 23) on October 1, 2025, with an ultimate completion date of March 31, 2026. This firm fixed-price contract, which carries no set-aside designation, will be performed in Greenwood Village, Colorado, and involves the provision of 503B compounded pharmaceutical products to support VA...
- Denver Solutions, LLC was awarded a $250,000 firm fixed price purchase order by the Defense Health Agency to provide various 503B compounded injectable pharmaceuticals. The place of performance is Greenwood Village, Colorado. The contract has a two year period of performance from July 2020 through July 2022. This requirement was set aside for total small businesses. Per the original solicitation from the Naval Supply Systems Command, the awarded contract supports the delivery of over 50...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,991.04 firm fixed-price delivery order is for the supply of 200 mg/20 ml vials of the drug Ketamine. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award, valued at $2,365.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566669347 - ROPIVACAINE 0.2% 400 MG/200 ML 200ML, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,355.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% 20 mg/10 mL in 10 mL vials. The contract, issued on September 3, 2025, with completion targeted for September 4, 2025, represents a direct procurement of pharmaceutical products to support military and federal healthcare operations. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's...
- This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government, specifically the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,929.64, is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
- This federal contract award is for the delivery of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., a major pharmaceutical distribution provider. The contract, valued at $102,677.64, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and is a Delivery Order under a larger...
This federal contract award, with an ID of 36C26121P1077, was issued by the Department of Veterans Affairs (VA) to Denver Solutions, LLC, a for-profit limited liability company based in Greenwood Village, Colorado. The contract is a firm fixed-price purchase order with a ceiling value of $95,470.00 and an ultimate completion date of September 30, 2021. The contract covers the delivery of various pharmaceutical products, including ropivacaine 0.2% 550mL, ephedrine 5mg/mL, ketamine 10mg/mL, and phenylephrine 100mcg/mL. These items are likely to be used in VA medical facilities to support healthcare services for veterans. Denver Solutions, LLC is an FDA-registered 503B outsourcing facility that specializes in providing compounded sterile pharmaceutical products to federal healthcare agencies, including the VA and the Defense Health Agency. The contract does not have a set-aside designation. In addition to this specific contract, Denver Solutions, LLC holds two significant Indefinite Delivery Contracts (IDCs) with the VA, one for liquid-filled implantable drug delivery systems (LEITERS) and the other for 503B compounded sterile pharmaceutical preparations. These IDCs, valued at $786,527.88 and $173,000, respectively, demonstrate the company's expertise in providing specialized pharmaceutical products and its established relationship with the VA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $95.5k | 6/1/21 |